Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis.
An unusual presentation of X-linked adrenoleukodystrophy.
The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling.
EAE: imperfect but useful models of multiple sclerosis.
Neuromyelitis optica spectrum disorders in Algeria: A preliminary study in the region of Tizi Ouzou.
Potassium channel antagonists 4-aminopyridine and the T-butyl carbamate derivative of 4-aminopyridine improve hind limb function in chronically non-ambulatory dogs; a blinded, placebo-controlled trial.
Patterns of Objective and Subjective Burden of Informal Caregivers in Multiple Sclerosis.
Behçet's syndrome: a critical digest of the 2012-2013 literature.
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis.
Assessments of nursing home guidelines for quality of care provided to residents with multiple sclerosis.
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.
Urodynamics in the Evaluation of the Patient with Multiple Sclerosis: When Are They Helpful and How Do We Use Them?
Oligoclonal Bands in Cerebrospinal Fluid of Black Patients with Multiple Sclerosis.
Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo.
Health Care Costs Associated With Geriatric Patients Diagnosed With Multiple Sclerosis Taking Disease Modifying Agents In The United States.
Epidemiology and Current Treatment of Neuromyelitis Optica: A Systematic Review.
Patch-Based Segmentation with Spatial Consistency: Application to MS Lesions in Brain MRI.
THC:CBD in Daily Practice: Available Data from UK, Germany and Spain.
Unfolding the Role of Large Heat Shock Proteins: New Insights and Therapeutic Implications.
Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Accumulation of Fascin+ cells during experimental autoimmune neuritis.
The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.
Microglia: Dynamic Mediators of Synapse Development and Plasticity.
Blockade of B-cell activating factor with TACI-IgG effectively reduced Th1 and Th17 cells but not memory T cells in experimental allergic encephalomyelitis mice.
Pages
« first
‹ previous
…
701
702
703
704
705
706
707
708
709
…
next ›
last »